Raymond James & Associates Cut Healthequity (HQY) Position; TD Ameritrade Holding (AMTD) Shorts Lowered By 9.6%

February 19, 2018 - By Ellis Scott

TD Ameritrade Holding Corporation (NASDAQ:AMTD) had a decrease of 9.6% in short interest. AMTD’s SI was 6.97M shares in February as released by FINRA. Its down 9.6% from 7.71M shares previously. With 2.00M avg volume, 4 days are for TD Ameritrade Holding Corporation (NASDAQ:AMTD)’s short sellers to cover AMTD’s short positions. The SI to TD Ameritrade Holding Corporation’s float is 2.87%. It closed at $56.29 lastly. It is down 21.10% since February 19, 2017 and is uptrending. It has outperformed by 4.40% the S&P500.

Raymond James & Associates decreased Healthequity Inc (HQY) stake by 32.68% reported in 2017Q3 SEC filing. Raymond James & Associates sold 18,782 shares as Healthequity Inc (HQY)’s stock rose 4.44%. The Raymond James & Associates holds 38,684 shares with $1.96 million value, down from 57,466 last quarter. Healthequity Inc now has $3.33 billion valuation. The stock increased 0.27% or $0.15 during the last trading session, reaching $54.86. About 557,290 shares traded or 3.12% up from the average. HealthEquity, Inc. (NASDAQ:HQY) has risen 95.58% since February 19, 2017 and is uptrending. It has outperformed by 78.88% the S&P500.

Among 13 analysts covering HealthEquity Inc (NASDAQ:HQY), 11 have Buy rating, 0 Sell and 2 Hold. Therefore 85% are positive. HealthEquity Inc had 32 analyst reports since August 18, 2015 according to SRatingsIntel. The rating was maintained by Cantor Fitzgerald with “Buy” on Wednesday, July 5. As per Tuesday, September 5, the company rating was maintained by Cantor Fitzgerald. The rating was maintained by Leerink Swann with “Outperform” on Monday, April 4. The rating was maintained by SunTrust with “Buy” on Wednesday, June 8. The firm has “Buy” rating by Cantor Fitzgerald given on Monday, August 28. Robert W. Baird maintained HealthEquity, Inc. (NASDAQ:HQY) rating on Wednesday, September 7. Robert W. Baird has “Neutral” rating and $35 target. The firm earned “Buy” rating on Friday, December 15 by Raymond James. The stock has “Overweight” rating by JP Morgan on Wednesday, January 24. The rating was maintained by Robert W. Baird on Tuesday, September 19 with “Hold”. Cantor Fitzgerald maintained HealthEquity, Inc. (NASDAQ:HQY) rating on Thursday, July 13. Cantor Fitzgerald has “Buy” rating and $5600 target.

Raymond James & Associates increased U S Concrete Inc (NASDAQ:USCR) stake by 4,551 shares to 14,855 valued at $1.13 million in 2017Q3. It also upped Hp Inc stake by 221,584 shares and now owns 1.11 million shares. Ishares Tr (ITB) was raised too.

Analysts await HealthEquity, Inc. (NASDAQ:HQY) to report earnings on March, 20. They expect $0.07 earnings per share, 0.00% or $0.00 from last year’s $0.07 per share. HQY’s profit will be $4.25 million for 195.93 P/E if the $0.07 EPS becomes a reality. After $0.17 actual earnings per share reported by HealthEquity, Inc. for the previous quarter, Wall Street now forecasts -58.82% negative EPS growth.

TD Ameritrade Holding Corporation provides securities brokerage services and related technology financial services to retail investors, traders, and independent registered investment advisors in the United States. The company has market cap of $31.94 billion. The Company’s services and products include tdameritrade.com, a Web platform for self-directed retail investors; Trade Architect, a Web platform for investors and traders to identify opportunities and stay informed; thinkorswim, a desktop platform for traders; and TD Ameritrade Mobile, which allows on-the-go investors and traders to trade and monitor accounts. It has a 32.06 P/E ratio. The firm also offers TD Ameritrade Institutional that provides brokerage and custody services to approximately 5,000 independent RIAs and their clients; TD Ameritrade's Goal Planning, which offers investment consulting and planning services; Investools, a suite of investor education services and products for stock, option, foreign exchange, futures, mutual fund, and fixed-income investors; Amerivest, an advisory service that develops portfolios of exchange-traded funds (ETFs) and mutual funds; AdvisorDirect, a national referral service for investors; and TD Ameritrade Corporate Services that provide self-directed brokerage services to employees of firms.

Among 8 analysts covering TD Ameritrade Holdings (NASDAQ:AMTD), 5 have Buy rating, 0 Sell and 3 Hold. Therefore 63% are positive. TD Ameritrade Holdings had 21 analyst reports since July 22, 2015 according to SRatingsIntel. The firm has “Outperform” rating given on Wednesday, October 7 by Keefe Bruyette & Woods. On Tuesday, January 12 the stock rating was upgraded by Citigroup to “Neutral”. Deutsche Bank maintained the stock with “Buy” rating in Friday, September 18 report. The rating was downgraded by Wells Fargo to “Market Perform” on Monday, September 28. Citigroup downgraded TD Ameritrade Holding Corporation (NASDAQ:AMTD) on Wednesday, July 22 to “Sell” rating. Deutsche Bank maintained the stock with “Buy” rating in Friday, January 8 report. The firm earned “Buy” rating on Wednesday, January 13 by Bank of America. The company was maintained on Wednesday, October 7 by Wood. The stock has “Buy” rating by UBS on Thursday, January 21.

- Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.

By

Free Email Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our FREE daily email newsletter:


>